E-LIB Suche - Ergebnisse für: Merker, Vanessa L

1

Views on the impact of the COVID‐19 pandemic on health in p..:

Santoro, Stephanie L. ; Baker, Sandra ; Blake, Jasmine M....
American Journal of Medical Genetics Part A. 191 (2023) 8 - p. 2045-2056 , 2023

Link: https://doi.org/10.1002/..

2

Indicators of health in Down syndrome: A virtual focus grou..:

Santoro, Stephanie L. ; Cabrera, Maria J. ; Haugen, Kelsey..
Journal of Applied Research in Intellectual Disabilities. 36 (2023) 2 - p. 354-365 , 2023

Link: https://doi.org/10.1111/..

3

INNV-33. NEURO-ONCOLOGY VISITS AT HOME (NOVAH): A PILOT PRO..:

Eichler, April ; Merker, Vanessa ; Von Imhof, Liesel...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v164-v164 , 2023

Link: https://doi.org/10.1093/..

4

NF1 Recommendation-Based Care Delivery: A Survey of Patient..:

Jordan, Justin ; Merker, Vanessa ; Chibnik, Lori...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

5

Ten-Year Follow-up of Internal Neurofibroma Growth Behavior..:

Ly, K. Ina ; Merker, Vanessa L. ; Cai, Wenli...
Neurology. 100 (2023) 7 - p. , 2023

Link: https://doi.org/10.1212/..

6

NIMG-07. LONG-TERM FOLLOW-UP OF SCHWANNOMA GROWTH BEHAVIOR ..:

Ly, Ina ; Merker, Vanessa ; Cai, Weni...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v185-v186 , 2023

Link: https://doi.org/10.1093/..

7

CTNI-80. INTUITT-NF2, AN ADAPTIVE PLATFORM-BASKET TRIAL FOR..:

Plotkin, Scott R ; Babovic-Vuksanovic, Dusica ; Dinh, Christine...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v96-v96 , 2023

Link: https://doi.org/10.1093/..

8

CTNI-79. PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLL..:

Plotkin, Scott R ; Da, Jennifer ; Silverman, Danielle...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v96-v96 , 2023

Link: https://doi.org/10.1093/..

9

Using Qualitative Interviews to Improve Quantitative Assess..:

Von Imhof, Liesel ; Plotkin, Scott ; Yohay, Kaleb...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

10

Advancing neurofibromatosis and schwannomatosis clinical tr..:

Merker, Vanessa L ; Gross, Andrea M ; Widemann, Brigitte C.
Clinical Trials. 21 (2023) 1 - p. 3-5 , 2023

Link: https://doi.org/10.1177/..

11

Recommendations for assessing appearance concerns related t..:

Merker, Vanessa L ; Thompson, Heather L ; Wolters, Pamela L...
Clinical Trials. , 2023

Link: https://doi.org/10.1177/..

12

Barriers to participation in a prospective clinical trial f..:

Plotkin, Scott ; Da, Jennifer ; Merker, Vanessa...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

13

CLRM-16 PATIENT-FOCUSED DRUG DEVELOPMENT IN NEURO-ONCOLOGY:..:

Merker, Vanessa ; Von Imhof, Liesel ; Park, Elyse...
Neuro-Oncology Advances. 4 (2022) Supplement_1 - p. i9-i9 , 2022

Link: https://doi.org/10.1093/..

14

Evaluating the Impacts of Patient Engagement on Health Serv..:

Merker, Vanessa L. ; Hyde, Justeen K. ; Herbst, Abigail...
Journal of General Internal Medicine. 37 (2022) S1 - p. 33-41 , 2022

Link: https://doi.org/10.1007/..

15

Understanding barriers to diagnosis in a rare, genetic dise..:

Merker, Vanessa L. ; Slobogean, Bronwyn ; Jordan, Justin T....
American Journal of Medical Genetics Part A. , 2022

Link: https://doi.org/10.1002/..